Terms: = Breast cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1 AND Treatment
35 results:
1. Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer.
Tsoi H; Lok J; Man EP; Cheng CN; Leung MH; You CP; Chan SY; Chan WL; Khoo US
J Pathol; 2023 Oct; 261(2):156-168. PubMed ID: 37555303
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα
Poulard C; Ha Pham T; Drouet Y; Jacquemetton J; Surmielova A; Kassem L; Mery B; Lasset C; Reboulet J; Treilleux I; Marangoni E; Trédan O; Le Romancer M
EMBO Mol Med; 2023 Aug; 15(8):e17248. PubMed ID: 37458145
[TBL] [Abstract] [Full Text] [Related]
3. Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive breast cancer.
Tsoi H; Tsang WC; Man EPS; Leung MH; You CP; Chan SY; Chan WL; Khoo US
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293165
[TBL] [Abstract] [Full Text] [Related]
4. Screening of organoids derived from patients with breast cancer implicates the repressor ncor2 in cytotoxic stress response and antitumor immunity.
Tsai KK; Huang SS; Northey JJ; Liao WY; Hsu CC; Cheng LH; Werner ME; Chuu CP; Chatterjee C; Lakins JN; Weaver VM
Nat Cancer; 2022 Jun; 3(6):734-752. PubMed ID: 35618935
[TBL] [Abstract] [Full Text] [Related]
5. Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.
Zhao J; Sun G; Zhu S; Dai J; Chen J; Zhang M; Ni Y; Zhang H; Shen P; Zhao X; Zhang B; Pan X; Nie L; Yin X; Liang J; Zhang X; Wang Z; Zhu X; Liao B; Liu Z; Armstrong CM; Gao AC; Huang H; Chen N; Zeng H
BJU Int; 2022 Mar; 129(3):345-355. PubMed ID: 34185954
[TBL] [Abstract] [Full Text] [Related]
6. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
Zhang X; Zhang B; Zhang P; Lian L; Li L; Qiu Z; Qian K; Chen A; Liu Q; Jiang Y; Cui J; Qi B
PLoS One; 2019; 14(5):e0217181. PubMed ID: 31120927
[TBL] [Abstract] [Full Text] [Related]
7. Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive.
Jordan VC
Clin Cancer Res; 2018 Aug; 24(15):3480-3482. PubMed ID: 29674510
[TBL] [Abstract] [Full Text] [Related]
8. BQ323636.1, a Novel Splice Variant to
Gong C; Man EPS; Tsoi H; Lee TKW; Lee P; Ma ST; Wong LS; Luk MY; Rakha EA; Green AR; Ellis IO; Lam EW; Cheung KL; Khoo US
Clin Cancer Res; 2018 Aug; 24(15):3681-3691. PubMed ID: 29420220
[No Abstract] [Full Text] [Related]
9. Sensitive detection of mitochondrial DNA variants for analysis of mitochondrial DNA-enriched extracts from frozen tumor tissue.
Weerts MJA; Timmermans EC; Vossen RHAM; van Strijp D; Van den Hout-van Vroonhoven MCGN; van IJcken WFJ; van der Zaag PJ; Anvar SY; Sleijfer S; Martens JWM
Sci Rep; 2018 Feb; 8(1):2261. PubMed ID: 29396409
[TBL] [Abstract] [Full Text] [Related]
10. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
[TBL] [Abstract] [Full Text] [Related]
11. Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer.
Collins DC; Cocchiglia S; Tibbitts P; Solon G; Bane FT; McBryan J; Treumann A; Eustace A; Hennessy B; Hill AD; Young LS
Oncogene; 2015 Jan; 34(4):525-30. PubMed ID: 24469058
[TBL] [Abstract] [Full Text] [Related]
12. SpliceArray profiling of breast cancer reveals a novel variant of ncor2/smrt that is associated with tamoxifen resistance and control of ERα transcriptional activity.
Zhang L; Gong C; Lau SL; Yang N; Wong OG; Cheung AN; Tsang JW; Chan KY; Khoo US
Cancer Res; 2013 Jan; 73(1):246-55. PubMed ID: 23117886
[TBL] [Abstract] [Full Text] [Related]
13. Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.
Cui J; Germer K; Wu T; Wang J; Luo J; Wang SC; Wang Q; Zhang X
Cancer Res; 2012 Nov; 72(21):5625-34. PubMed ID: 22964581
[TBL] [Abstract] [Full Text] [Related]
14. Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.
Cutrupi S; Reineri S; Panetto A; Grosso E; Caizzi L; Ricci L; Friard O; Agati S; Scatolini M; Chiorino G; Lykkesfeldt AE; De Bortoli M
Oncogene; 2012 Oct; 31(40):4353-61. PubMed ID: 22249258
[TBL] [Abstract] [Full Text] [Related]
15. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.
Sircoulomb F; Nicolas N; Ferrari A; Finetti P; Bekhouche I; Rousselet E; Lonigro A; Adélaïde J; Baudelet E; Esteyriès S; Wicinski J; Audebert S; Charafe-Jauffret E; Jacquemier J; Lopez M; Borg JP; Sotiriou C; Popovici C; Bertucci F; Birnbaum D; Chaffanet M; Ginestier C
EMBO Mol Med; 2011 Mar; 3(3):153-66. PubMed ID: 21328542
[TBL] [Abstract] [Full Text] [Related]
16. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.
Langer W; Sohler F; Leder G; Beckmann G; Seidel H; Gröne J; Hummel M; Sommer A
BMC Genomics; 2010 Nov; 11():676. PubMed ID: 21118496
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of MAP kinase promotes the recruitment of corepressor smrt by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells.
Hong W; Chen L; Li J; Yao Z
Biochem Biophys Res Commun; 2010 May; 396(2):299-303. PubMed ID: 20406620
[TBL] [Abstract] [Full Text] [Related]
18. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract] [Full Text] [Related]
19. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.
Liu T; Liu Y; Kao HY; Pei D
J Med Chem; 2010 Mar; 53(6):2494-501. PubMed ID: 20180533
[TBL] [Abstract] [Full Text] [Related]
20. CITED2 and ncor2 in anti-oestrogen resistance and progression of breast cancer.
van Agthoven T; Sieuwerts AM; Veldscholte J; Meijer-van Gelder ME; Smid M; Brinkman A; den Dekker AT; Leroy IM; van Ijcken WF; Sleijfer S; Foekens JA; Dorssers LC
Br J Cancer; 2009 Dec; 101(11):1824-32. PubMed ID: 19904269
[TBL] [Abstract] [Full Text] [Related]
[Next]
